Tarriff Scott

CEO and President at EAGLE PHARMACEUTICALS, INC.

Sold, on record
$24.4M
Dollars the filings state
Form 4 sales
18
Latest Nov 2, 2023
Form 144 notices
5
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale EAGLE PHARMACEUTICALS, INC.No plan
    May 15 2023

    Sold 45,000 shares at $20.68 ($931k)

    Tarriff Scott, CEO

    No 10b5-1 planSold 2.7% of holdings ($33.9M position)1.6M shares leftFirst sale on recordFollows a Form 144Filing

  2. 2 Form 4 sale EAGLE PHARMACEUTICALS, INC.No plan
    May 16 +1 day

    Sold 15,000 shares at $19.98 ($300k)

    Tarriff Scott, CEO

    No 10b5-1 planSold 2.5% of holdings ($12M position)587,311 shares leftFollows a Form 144Filing

  3. 3 Form 144 notice EAGLE PHARMACEUTICALS, INC.Notice
    Oct 2 +139 days

    Filed to sell 9,511 shares ($150k)

    Tarriff Scott, CEO and President

    10b5-1 planFiling

  4. 4 Form 144 notice EAGLE PHARMACEUTICALS, INC.Notice
    Oct 3 +1 day

    Filed to sell 10,734 shares ($155k)

    Tarriff Scott, CEO and President

    10b5-1 planFiling

  5. 5 Form 4 sale EAGLE PHARMACEUTICALS, INC.Routine
    Oct 3 same day

    Sold 20,245 shares at $14.82 ($300k)

    Tarriff Scott, CEO

    10b5-1 planSold 3.4% of holdings ($8.7M position)567,066 shares leftFollows a Form 144Filing

  6. 6 Form 144 notice EAGLE PHARMACEUTICALS, INC.Notice
    Nov 1 +29 days

    Filed to sell 10,925 shares ($150k)

    Tarriff Scott, CEO and President

    10b5-1 plan0.5x usual sizeFiling

  7. 7 Form 144 notice EAGLE PHARMACEUTICALS, INC.Notice
    Nov 2 +1 day

    Filed to sell 10,694 shares ($150k)

    Tarriff Scott, CEO and President

    10b5-1 plan0.5x usual sizeFiling

  8. 8 Form 4 sale EAGLE PHARMACEUTICALS, INC.Routine
    Nov 2 same day

    Sold 21,619 shares at $13.84 ($299k)

    Tarriff Scott, CEO

    10b5-1 planSold 3.8% of holdings ($7.9M position)545,447 shares left1.1x usual sizeFollows a Form 144Filing

Every transaction

Loading transactions…

Sales and notices (23)

Form 144 notices and Form 4 sales by Tarriff Scott
Source
Nov 2, 2023EAGLE PHARMACEUTICALS, INC.CEOForm 4 sale21,619$299k3.8%RoutineSEC
Nov 2, 2023EAGLE PHARMACEUTICALS, INC.CEO and PresidentForm 144 notice10,694$150kNoticeSEC
Nov 1, 2023EAGLE PHARMACEUTICALS, INC.CEO and PresidentForm 144 notice10,925$150kNoticeSEC
Oct 3, 2023EAGLE PHARMACEUTICALS, INC.CEOForm 4 sale20,245$300k3.4%RoutineSEC
Oct 3, 2023EAGLE PHARMACEUTICALS, INC.CEO and PresidentForm 144 notice10,734$155kNoticeSEC
Oct 2, 2023EAGLE PHARMACEUTICALS, INC.CEO and PresidentForm 144 notice9,511$150kNoticeSEC
May 16, 2023EAGLE PHARMACEUTICALS, INC.CEOForm 4 sale15,000$300k2.5%No planSEC
May 15, 2023EAGLE PHARMACEUTICALS, INC.CEOForm 4 sale45,000$931k2.7%No planSEC
May 11, 2023EAGLE PHARMACEUTICALS, INC.CEO and PresidentForm 144 notice60,000$1.3MNoticeSEC
Apr 1, 2019EAGLE PHARMACEUTICALS, INC.CEOForm 4 sale24,975$1.3M1.6%Plan not statedSEC
Mar 1, 2019EAGLE PHARMACEUTICALS, INC.CEOForm 4 sale24,428$1.3M1.6%Plan not statedSEC
Feb 1, 2019EAGLE PHARMACEUTICALS, INC.CEOForm 4 sale30,085$1.2M1.9%Plan not statedSEC
Jan 3, 2019EAGLE PHARMACEUTICALS, INC.CEOForm 4 sale31,569$1.2M2.0%Plan not statedSEC
Apr 1, 2016EAGLE PHARMACEUTICALS, INC.President and CEOForm 4 sale30,765$1.2M2.2%Plan not statedSEC
Mar 1, 2016EAGLE PHARMACEUTICALS, INC.President and CEOForm 4 sale19,780$1.3M1.4%Plan not statedSEC
Feb 1, 2016EAGLE PHARMACEUTICALS, INC.President and CEOForm 4 sale18,360$1.2M1.3%Plan not statedSEC
Jan 4, 2016EAGLE PHARMACEUTICALS, INC.President and CEOForm 4 sale14,549$1.2M1.0%Plan not statedSEC
Dec 1, 2015EAGLE PHARMACEUTICALS, INC.President and CEOForm 4 sale14,050$1.2M1.0%Plan not statedSEC
Nov 2, 2015EAGLE PHARMACEUTICALS, INC.President and CEOForm 4 sale19,339$1.2M1.3%Plan not statedSEC
Oct 1, 2015EAGLE PHARMACEUTICALS, INC.President and CEOForm 4 sale17,878$1.2M1.2%Plan not statedSEC
Sep 1, 2015EAGLE PHARMACEUTICALS, INC.President and CEOForm 4 sale16,245$1.2M1.1%Plan not statedSEC
Aug 3, 2015EAGLE PHARMACEUTICALS, INC.President and CEOForm 4 sale13,000$1.3M0.8%Plan not statedSEC
Jul 1, 2015EAGLE PHARMACEUTICALS, INC.President and CEOForm 4 sale135,710$6.3M8.1%Plan not statedSEC